How is the Passage Bio Inc today?

The Passage Bio Inc today is trading in the green, up by 2.63% at 0.39.

How has Passage Bio Inc performed historically?

The Passage Bio Inc is currently trading up 2.63% on an intraday basis in the past week the index fell -15.22%. The index has been down -13.33% in the past quarter and fell -59.38% in the past year. You can view this in the overview section.

What is Passage Bio Inc Annual Net Profit?

Passage Bio Inc Annual Net Profit rose 36.54% in the last year to $64.77 M. Its sector's average net profit growth for the last fiscal year was -14.04%.

What is Passage Bio Inc Price to Earning Ratio?

Passage Bio Inc Price to Earning Ratio is -0.38, which is negative.

What is Passage Bio Inc Stock Price?

Passage Bio Inc Stock Price fell 59.38% and underperformed its sector by 486.47% in the past year.

What is Passage Bio Inc Quarterly Net profit?

Passage Bio Inc Quarterly Net profit rose 7.82% YoY to $15.4 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is Passage Bio Inc Debt to Equity Ratio?

Passage Bio Inc Debt to Equity Ratio of 0.42 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Passage Bio Inc Return on Equity(ROE)?

Passage Bio Inc Return on Equity(ROE) for the last financial year was -75.07%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Passage Bio Inc Mutual Fund Holding?

Passage Bio Inc Mutual Fund Holding increased by 0.05% in the last quarter to 9.99.

What is Passage Bio Inc Promoter Share Holding?

Passage Bio Inc Promoter Share Holding stayed the same in the most recent quarter at 0.25%.

What is Passage Bio Inc Institutional Holding?

Passage Bio Inc Institutional Holding decreased by 0.63% in the last quarter to 43.85.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
PASSAGE BIO INC

Passage Bio Inc XNAS: PASG

Passage Bio Inc Live Share Price Today, Share Analysis and Chart

Name: Passage Bio Inc: Is Infosys Ltd. worth buying?
Item: Passage Bio Inc
Rating: 1.31500
Author: Trendlyne DVM scores

about

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Com...

0.39 0.01 (2.63%)

70.68% Fall from 52W High

94,985

XNAS Volume

XNAS 18 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.5 / 100

Technically Neutral

38.1 / 100

No estimates available

Passage Bio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Passage Bio Inc Live Share Price Today, Share Analysis and Chart

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Com...

70.68% Fall from 52W High

SWOT Analysis

Passage Bio Inc Live Price Chart

Passage Bio Inc FAQ

How is Passage Bio Inc today?

Passage Bio Inc today is trading in the green, and is up by 2.63% at 0.39.

How has Passage Bio Inc performed historically?

Passage Bio Inc is currently trading up 2.63% on an intraday basis. In the past week the stock fell -15.22%. stock has been down -13.33% in the past quarter and fell -59.38% in the past year. You can view this in the overview section.